Patient Selection
The study population is patients older than 18 years old who visited
Fatemeh Zahra Sari Heart Hospital, located in the north of Iran, between
September 2017 and August 2018 and underwent PPCI with STEMI. The people
in the study included patients who had chest pain suggestive of
myocardial infarction from at least 30 minutes before admission to a
maximum of 12 hours before going to the hospital with an ECG suggestive
of STEMI.
Patients who presented with cardiogenic shock, patients who became
candidates for PCI after receiving fibrinolytics, patients who became
candidates for emergent CABGs after angiography, patients under 18 years
old or over 80 years old, pregnant patients, patients with kidney or
liver failure and Patients who had contraindications for eptifibatide
use (active internal bleeding, brain neoplasm or aneurysm, stroke in the
last two years, intracerebral trauma or surgery in the last two months,
uncontrolled high blood pressure, and thrombocytopenia) were excluded
from the study.